Polygenic Risk Score analysis for Alzheimer's disease risk

Sponsored by: Thermo Fisher Scientific - Applied Biosystems

Speaker

Event Date & Time

DATE: November 8, 2019

TIME: 8:00am PT, 11:00am ET

Abstract

The utility of Polygenic Risk Scores (PRS) is gaining researchers' attention for identifying individual genetic risk and disease risk prediction in Alzheimer's Disease (AD) at both the early and pre-symptomatic stages of the disease. genoSCORE™ combines Cytox's proprietary technologies variaTECT™, a proprietary single nucleotide polymorphism (SNP) profiling array built on the Axiom platform from Thermo Fisher Scientific, with the SNPfitR™ analytical and interpretive software incorporating algorithms developed in partnership with Cardiff University, to give a PRS that identifies any individual's genetic risk of developing AD from blood or saliva-extracted DNA. This can help in patient stratification for clinical trial research to develop targeted treatments for AD.

Learning Objectives:

Select the highest risk APOE3/E4 subjects mostly likely to develop AD
Identify highest/low risk APOE3/E3 subjects for inclusion/exclusion in clinical studies

Webinars will be available for unlimited on-demand viewing after live event.

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.